BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34109436)

  • 1. Curcumin induces apoptosis by inhibiting BCAT1 expression and mTOR signaling in cytarabine‑resistant myeloid leukemia cells.
    Tseng YH; Yang RC; Chiou SS; Shieh TM; Shih YH; Lin PC
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant acute myeloid leukemia cells.
    Hancio T; Mazzoccoli L; Guimarães G; Robaina M; Mendonça BDS; Nestal De Moraes G; Monte-Mor BDCR; Mayumi Gutiyama L; De Carvalho LO; Netto CD; Costa PRR; De Faria FCC; Maia RC
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33786613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
    Zhang L; Han J
    Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells.
    Guo Y; Shan Q; Gong Y; Lin J; Shi F; Shi R; Yang X
    Pharmazie; 2014 Mar; 69(3):229-33. PubMed ID: 24716415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
    Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
    Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation.
    Raffel S; Falcone M; Kneisel N; Hansson J; Wang W; Lutz C; Bullinger L; Poschet G; Nonnenmacher Y; Barnert A; Bahr C; Zeisberger P; Przybylla A; Sohn M; Tönjes M; Erez A; Adler L; Jensen P; Scholl C; Fröhling S; Cocciardi S; Wuchter P; Thiede C; Flörcken A; Westermann J; Ehninger G; Lichter P; Hiller K; Hell R; Herrmann C; Ho AD; Krijgsveld J; Radlwimmer B; Trumpp A
    Nature; 2017 Nov; 551(7680):384-388. PubMed ID: 29144447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
    Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
    J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin and tetrahydrocurcumin induce cell death in Ara-C-resistant acute myeloid leukemia.
    Tseng YH; Chiou SS; Weng JP; Lin PC
    Phytother Res; 2019 Apr; 33(4):1199-1207. PubMed ID: 30834607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F; Gao S; Yang Y; Zhao X; Fan Y; Ma W; Yang D; Yang A; Yu Y
    Oncol Rep; 2018 Mar; 39(3):1523-1531. PubMed ID: 29328421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin inhibits the proliferation and survival of acute myeloid leukaemia cells through down-regulating TNS1.
    Sun X; Yang S; Song W
    Biomed Pharmacother; 2020 Apr; 124():109731. PubMed ID: 31954876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
    Shah K; Mirza S; Desai U; Jain N; Rawal R
    Anticancer Agents Med Chem; 2016; 16(1):128-35. PubMed ID: 26278546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.
    Pan J; Wang Y; Huang S; Mao S; Ling Q; Li C; Li F; Yu M; Huang X; Huang J; Lv Y; Li X; Ye W; Wang H; Wang J; Jin J
    J Mol Med (Berl); 2024 Mar; 102(3):415-433. PubMed ID: 38340163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apatinib enhances chemosensitivity of acute myeloid leukemia hl60 cells to cytarabine by inducing apoptosis.
    Pan Q; Wang J; Jiang X; Yang E; Dong L; Gu K
    J BUON; 2019; 24(1):374-381. PubMed ID: 30941994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.
    Liu LL; Long ZJ; Wang LX; Zheng FM; Fang ZG; Yan M; Xu DF; Chen JJ; Wang SW; Lin DJ; Liu Q
    Mol Cancer Res; 2013 Nov; 11(11):1326-36. PubMed ID: 24008673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation.
    Shakor AB; Atia M; Ismail IA; Alshehri A; El-Refaey H; Kwiatkowska K; Sobota A
    Biochim Biophys Acta; 2014 Dec; 1841(12):1672-82. PubMed ID: 25240837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
    Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
    Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines.
    Ibrahim SM; Bakhashab S; Ilyas AM; Pushparaj PN; Karim S; Khan JA; Abuzenadah AM; Chaudhary AG; Al-Qahtani MH; Ahmed F
    Oncol Rep; 2019 Jun; 41(6):3179-3188. PubMed ID: 30942458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro anti-leukemia activity of dual PI3K/mTOR inhibitor Voxtalisib on HL60 and K562 cells, as well as their multidrug resistance counterparts HL60/ADR and K562/A02 cells.
    Zhang L; Wang Z; Khishignyam T; Chen T; Zhou C; Zhang Z; Jin M; Wang R; Qiu Y; Kong D
    Biomed Pharmacother; 2018 Jul; 103():1069-1078. PubMed ID: 29710665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.